Previous studies have shown that CD4+ CD39+ T cells (28) and CD8+ T cells double positive (DP) for CD39 and CD103 contain a high frequency of tumor-reactive T cells (26), but these subsets of T cells have not yet been studied in pancreatic cancer. The gene discussed is ENTPD1; the disease is pancreatic neoplasm.